Laimei Pharmaceuticals: Guojin Securities Summary Report on Continued Supervision and Sponsorship of Laimei Pharmaceuticals Issuance of Shares to Specific Targets in 2021
Laimei Pharmaceuticals: Shareholder dividend return plan for the next three years (2024-2026)
Laimei Pharmaceuticals: An indicative announcement on the issuance of shares to specific targets, the listing and circulation of restricted shares
Laimei Pharmaceutical: Announcement on the expiration of the passive holdings reduction period for shareholders holding 5% or more
Laimei Pharmaceutical: Announcement on the passive reduction of holdings of some shares held by shareholders holding 5% or more of the shares by more than half
Laimei Pharmaceutical: Pre-disclosure Notice on Passive Reduction of Some Shares Held by Shareholders Holding 5% or More
Laimei Pharmaceutical: Announcement on the progress of share transfers of subsidiary companies and the signing of the “Supplementary Agreement to the Equity Transfer Agreement (2)”
Laimei Pharmaceutical: Chongqing Laimei Pharmaceutical Co., Ltd. Simplified Equity Change Report
Laimei Pharmaceutical: Prompt Notice on Disclosure of a Simplified Statement of Changes in Equity
Laimei Pharmaceutical: Announcement on the change in the controlling shareholder's equity to reach 1%
Laimei Pharmaceutical: Announcement on the progress of the second judicial auction of shares held by shareholders holding 5% or more of the shares
Laimei Pharmaceutical: An indicative announcement on shares held by shareholders holding 5% or more of the shares to be judicially auctioned for the second time
Laimei Pharmaceutical: Announcement on the forensic auction of some of the company's shares held by shareholders holding 5% or more of the shares
Laimei Pharmaceutical: Pre-disclosure announcement on the proposed judicial auction and passive reduction of some of the company's shares held by shareholders holding 5% or more of the shares
Laimei Pharmaceutical: Announcement on the transfer of some of the company's shares held by shareholders holding 5% or more of the shares through a judicial auction
Laimei Pharmaceutical: Announcement on the transfer of company shares held by unanimous actors holding 5% or more of the shares through judicial auction and the share change ratio exceeding 1%
Laimei Pharmaceutical: Announcement on the progress of shareholders' shares being judicially auctioned for the second time
Laimei Pharmaceutical: An indicative announcement that shareholders' shares will be judicially auctioned for the second time
Laimei Pharmaceutical: 01 Laimei Pharmaceutical's Simplified Equity Change Report
Laimei Pharmaceutical: An indicative announcement on the completion of transfer and changes in equity of some of the company's shares held by shareholders holding 5% or more of the company's shares through judicial auction
No Data